SCHEMBL6101016

SCHEMBL6101016

CC(=O)Nc1ccc(-c2ccc(C(=O)N3CCc4cc(F)c(N5C[C@@H](C)N[C@@H](C)C5)cc43)cc2)c(C)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 10/20 0.56
HTR1B P28222 10/20 0.56
PDK1 Q15118 3/20 0.43
PDK2 Q15119 3/20 0.43
PDK3 Q15120 3/20 0.43
PDK4 Q16654 3/20 0.43
HTR1A P08908 1/20 0.42
MAPT P10636 3/20 0.37
ALDH1A1 P00352 1/20 0.37
RAB9A P51151 1/20 0.37
XIAP P98170 1/20 0.36
BIRC2 Q13490 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
CYP11B2 P19099 1/20 0.35
HTR2A P28223 2/20 0.34
MAPK1 P28482 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6102054 0.89 HTR1D (0.55) HTR1DHTR1BPDK1PDK2PDK3
SCHEMBL6168850 0.89 HTR1D (0.71) HTR1DHTR1BPDK1PDK2PDK3
SCHEMBL6102593 0.89 HTR1D (0.71) HTR1DHTR1BPDK1PDK2PDK3
SCHEMBL6102410 0.86 HTR1D (0.66) HTR1DHTR1BPDK1PDK2PDK3
SCHEMBL6101634 0.85 HTR1D (0.57) HTR1DHTR1BHTR1AMAPTALDH1A1
SCHEMBL6099612 0.82 HTR1D (0.55) HTR1DHTR1BHTR1AMAPTALDH1A1
SCHEMBL6101776 0.81 HTR1D (0.61) HTR1DHTR1BHTR1ATP53LMNA
SCHEMBL6101088 0.79 HTR1D (0.69) HTR1DHTR1BPDK1PDK2PDK3
SCHEMBL6101864 0.79 HTR1D (0.63) HTR1DHTR1BHTR1AMAPTALDH1A1
SCHEMBL6101028 0.78 HTR1D (0.60) HTR1DHTR1BHTR1AMAPTXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7109201-B2 Piperazine derivatives, their preparation and uses in therapy SMITHKLINE BEECHAM PLC (GB) 2006-09-19 US claimed